7 Third Avenue Management Supernus Pharmaceuticals Trades
Third Avenue Management acquired 153k Supernus Pharmaceuticals shares worth $6.83M. That's 1.07% of their equity portfolio (29th largest holding). Third Avenue Management started to build up the position in Supernus Pharmaceuticals in Q2 2022 and continued to invest until Q3 2024. Since then they sold 36.8k shares. The stake costed the investor $4.71M, netting the investor a gain of 45% so far.
News about Supernus Pharmaceuticals Inc and Third Avenue Management
New York Life Investment Management LLC Lowers Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
New York Life Investment Management LLC decreased its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 25.5% during the first quarter, ...
Mitsubishi UFJ Asset Management UK Ltd. Buys New Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Mitsubishi UFJ Asset Management UK Ltd. acquired a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) in the third quarter, according to the company i...
Radcliffe Capital Management, L.P. Buys Supernus Pharmaceuticals Inc, BlackRock Capital ...
Related Stocks: DHHC , GFX , VYGG , SUPN , BKCC , DISH , INVA , GSBD , SIERU , GACQU , CENH , GIWWU , CAP , DEH , MAAC ,